Details for Patent: 7,276,250
✉ Email this page to a colleague
Summary for Patent: 7,276,250
| Title: | Sustained release formulations of oxymorphone |
| Abstract: | Sustained release formulations of oxymorphone or pharmaceutically acceptable salts thereof; methods for making the sustained release formulations of oxymorphone or pharmaceutically acceptable salts thereof; and methods for using the sustained release formulations of oxymorphone or pharmaceutically acceptable salts thereof to treat patients suffering from pain are provided. |
| Inventor(s): | Baichwal; Anand R. (Wappingers Falls, NY), Kao; Huai-Hung (Syosset, NY), McCall; Troy W. (Germantown, TN) |
| Assignee: | Penwest Pharmaceuticals Company (Danbury, CT) |
| Application Number: | 10/189,932 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 7,276,250 |
|
Patent Claim Types: see list of patent claims | Formulation; Compound; Delivery; Use; Dosage form; |
Drugs Protected by US Patent 7,276,250
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 7,276,250
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Austria | 359077 | ⤷ Sign Up | |||
| Austria | 376832 | ⤷ Sign Up | |||
| Australia | 2002316582 | ⤷ Sign Up | |||
| Australia | 2002318211 | ⤷ Sign Up | |||
| Australia | 2002320309 | ⤷ Sign Up | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
